BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4471059)

  • 1. Observations on the use of hycanthone in a split dosage in the treatment of Schistosomiasis mansoni.
    Rees PH; Roberts JM; Rbook J; Munguti J
    Egypt J Bilharz; 1974; 1(2):203-7. PubMed ID: 4471059
    [No Abstract]   [Full Text] [Related]  

  • 2. Hycanthone in experimental schistosomiasis studies on liver pathology in mice treated with one and two doses.
    Farag HF; Guirguis RS; Sherif A; Hanna AT
    J Egypt Med Assoc; 1976; 59(5-6):439-47. PubMed ID: 1032313
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hycanthone in a single intramuscular dose. Therapeutic results obtained in subjects excreting S. mansoni eggs and treated at Kapolowe (region of the artificial lake of Lufira, Republic of Zaire)].
    Raccurt C; Grimaud JA; Ripert C
    Bull Soc Pathol Exot Filiales; 1974; 67(4):425-35. PubMed ID: 4480532
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials of hycanthone in schistosomiasis mansoni in St. Lucia.
    Cook JA; Jordan P
    Egypt J Bilharz; 1974; 1(2):197-202. PubMed ID: 4471058
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial with hycanthone in the treatment of schistosomiasis mansoni].
    Huggins D
    An Inst Hig Med Trop (Lisb); 1974; 2(1-4):553-9. PubMed ID: 4462403
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of schistosomiasis mansoni with hycanthone (our experience in 3,500 cases)].
    Huggins D
    G E N; 1978; 32(3):295-301. PubMed ID: 110648
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of schistosomiasis mansoni in Murang'a District, Kenya: a double blind controlled trial of three hycanthone regimens and oxamniquine.
    Rees PH; Bowry HN; Roberts JM; Thuku JJ
    Am J Trop Med Hyg; 1975 Sep; 24(5):823-6. PubMed ID: 1190368
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of schistosomiasis using hycanthone in 246 children. Side effects, laboratory studies and efficacy of various doses].
    Soares D; Guimarães RX; Domingues SH; de Pádua Vilela M
    AMB Rev Assoc Med Bras; 1975 Mar; 21(3):89-91. PubMed ID: 1079617
    [No Abstract]   [Full Text] [Related]  

  • 9. Hycanthone dose-response in Schistosoma mansoni infection in Kenya.
    Warren KS; Siongok TK; Ouma JH; Houser HB
    Lancet; 1978 Feb; 1(8060):352-4. PubMed ID: 75394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hycanthone dose-response in treatment of schistosomiasis mansoni in St. Lucia.
    Cook JA; Jordan P; Armitage P
    Am J Trop Med Hyg; 1976 Jul; 25(4):602-7. PubMed ID: 961979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the clinical pharmacology of hycanthone.
    Dennis EW; Kobus W
    Egypt J Bilharz; 1974; 1(1):35-53. PubMed ID: 4619885
    [No Abstract]   [Full Text] [Related]  

  • 12. Experiences with hycanthone methanesulfonate (etrenol) in the treatment of S. mansoni.
    Ongom VL
    Egypt J Bilharz; 1974; 1(2):209-13. PubMed ID: 4377908
    [No Abstract]   [Full Text] [Related]  

  • 13. [Electrocardiographic changes in patients with schistosomiasis mansoni treated with hycanthone].
    Takaoka L; Baldy JL; Passos JD; Soares EC; Zeitune JM; Siqueira JE
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):378-86. PubMed ID: 1006067
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of oral therapy of mansonial schistosomiasis in the Sudan using single and multiple doses of hycanthone and oxamniquine drugs.
    Magzoub M; Adam SE
    J Pharmacol Exp Ther; 1978 Aug; 206(2):382-7. PubMed ID: 682120
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical treatment of schistosomiasis mansoni with a new schistosomicidal agent: hycanthone or etrenol.
    Sotomayor ZR; Febles F; Ramos Morales F; Sanchez G; Rivera M
    J Trop Med Hyg; 1976 Jan; 79(1):18-21. PubMed ID: 772233
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic evolution of schistosomiasis mansoni. Results obtained with the use of hycanthone (Etrenol), during corticosteroid therapy].
    Asfora J; Lúcia Coutinho Domingues A
    An Inst Hig Med Trop (Lisb); 1974; 2(1-4):521-33. PubMed ID: 4462401
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience with hycanthone in 3,100 carriers of schistosomiasis mansoni].
    Buaiz V; Goncalves CS; Zanotti WM; Boni ES; Pereira FE
    AMB Rev Assoc Med Bras; 1976 May; 22(5):171-4. PubMed ID: 1085945
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of schistosomiasis mansoni infection using hycanthone (our current experience in 3,400 cases)].
    Huggins D
    An Inst Hig Med Trop (Lisb); 1975; 3(1-4):261-5. PubMed ID: 1235036
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunoglobulins level in patients with schistosomiasis mansoni after hycanthone treatment].
    Curiel M
    G E N; 1977; 32(2):141-51. PubMed ID: 97156
    [No Abstract]   [Full Text] [Related]  

  • 20. Hycanthone in the treatment of Egyptian bilharzial patients.
    Gawish N
    Egypt J Bilharz; 1976; 3(1):107-13. PubMed ID: 1029644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.